• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Agfa signs up Inphact to supply CR, PACS via ASP

Article

Agfa signs up Inphact to supply CR, PACS via ASPAgfa has signed a purchase and supply agreement with Nashville, TN-based Inphact to provide Agfa CR and PACS products, service, and support to community hospitals and clinics on an application

Agfa signs up Inphact to supply CR, PACS via ASP

Agfa has signed a purchase and supply agreement with Nashville, TN-based Inphact to provide Agfa CR and PACS products, service, and support to community hospitals and clinics on an application service provider basis. Through its ASP service, Inphact enables imaging departments to “rent” its technology platform, which includes digital acquisition equipment, information software, image distribution, and the archive. Customers are charged on a per-procedure basis. Inphact says this latest contract with Agfa will be worth at least $5 million over the next 14 months.

In related news, Agfa has taken a majority position in RIS vendor Quadrat. The two Belgian firms now plan to accelerate the integration of RIS technology into Agfa’s Impax PACS product and pursue further development of electronic patient record technologies.

Recent Videos
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, MD, Part 2
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, Part 1
Addressing Cybersecurity Issues in Radiology
Computed Tomography Study Shows Emergence of Silicosis in Engineered Stone Countertop Workers
Can an Emerging AI Software for DBT Help Reduce Disparities in Breast Cancer Screening?
Skeletal Muscle Loss and Dementia: What Emerging MRI Research Reveals
Magnetoencephalopathy Study Suggests Link Between Concussions and Slower Aperiodic Activity in Adolescent Football Players
Radiology Study Finds Increasing Rates of Non-Physician Practitioner Image Interpretation in Office Settings
Related Content
© 2025 MJH Life Sciences

All rights reserved.